Curcuma comosa Diarylheptanoids Attenuate LPS-induced Neuroinflammatory Responses via NF-κB Signaling in Microglial Cells: Comparison with Genistein and Estrogen
Trends in Sciences · 05.09.2026 · 24 (1) · 14105
DOI: 10.48048/tis.2027.14105 ↗Kurz gefasst
Fachartikel in der Zeitschrift Trends in Sciences, online erschienen am 05.09.2026. Verfasst von Busarat Karachot und 4 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Microglial activation is a hallmark of neuroinflammation in several neurodegenerative disorders, including Parkinson’s disease (PD), Alzheimer’s disease (AD), and AIDS dementia complex. Inhibition of excessive production of pro-inflammatory mediators represents a promising strategy for mitigating neuroinflammatory responses. In menopausal women, declining estrogen levels are associated with increased neuroinflammation and a higher risk of neurodegenerative disorders. Although estrogen replacement therapy exerts anti-inflammatory effects, concerns regarding adverse events have prompted interest in alternative interventions. This study investigated the anti-inflammatory mechanisms of two diarylheptanoids isolated from Curcuma comosa (compounds 049 and 092) in comparison with genistein and estrogen in an LPS-induced microglial activation model. Compounds 049 and 092, as well as genistein and estrogen, significantly reduced nitric oxide (NO) and prostaglandin E2 (PGE2) production, accompanied by downregulation of inducible nitric oxide synthase (iNOS) and cyclooxygenase-2 (COX-2) at both mRNA and protein levels. These effects were associated with reduced phosphorylation of IKKα/IKKβ, IκBα, and NF-κB p65. Collectively, the findings indicate that C. comosa diarylheptanoids attenuate microglial inflammatory responses through modulation of NF-κB-associated signaling pathways. Under the experimental conditions employed, compounds 049 and 092 exhibited anti-inflammatory effects comparable to those observed with genistein and estrogen, supporting further investigation of their neuroprotective potential. HIGHLIGHTS This study provides the first direct comparison of Curcuma comosa-derived diarylheptanoids (compounds 049 and 092) with genistein and estrogen in an LPS-induced microglial activation model. Compounds 049 and 092 inhibit LPS-induced NO and PGE2 production in HAPI microglial cells without reducing cell viability. Both diarylheptanoids downregulate iNOS and COX-2 expression at the mRNA and protein levels. Compounds 049 and 092 attenuate LPS-induced phosphorylation of IKKα//IKKβ, IκBα, and NF-κB p Their anti-inflammatory profiles are broadly comparable to those of genistein and estrogen, supporting further investigation of their potential as modulators of neuroinflammation. GRAPHICAL ABSTRACT
Zitieren
APA
Karachot, B., Thampithak, A., Jantaratnotai, N., Suksamrarn, A., & Sanvarinda, P. (2026). Curcuma comosa Diarylheptanoids Attenuate LPS-induced Neuroinflammatory Responses via NF-κB Signaling in Microglial Cells: Comparison with Genistein and Estrogen. Trends in Sciences, 24(1), 14105. https://doi.org/10.48048/tis.2027.14105
Vancouver
Karachot B, Thampithak A, Jantaratnotai N, Suksamrarn A, Sanvarinda P. Curcuma comosa Diarylheptanoids Attenuate LPS-induced Neuroinflammatory Responses via NF-κB Signaling in Microglial Cells: Comparison with Genistein and Estrogen. Trends in Sciences. 2026;24(1):14105. doi:10.48048/tis.2027.14105
BibTeX
@article{Karachot2026,
author = {Karachot, Busarat and Thampithak, Anusorn and Jantaratnotai, Nattinee and Suksamrarn, Apichart and Sanvarinda, Pimtip},
title = {Curcuma comosa Diarylheptanoids Attenuate LPS-induced Neuroinflammatory Responses via NF-κB Signaling in Microglial Cells: Comparison with Genistein and Estrogen},
journal = {Trends in Sciences},
year = {2026},
volume = {24},
number = {1},
pages = {14105},
doi = {10.48048/tis.2027.14105}
}
EUVIMED